E-LIB Suche - Ergebnisse für: Miller, Tamara A

1

Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by ..:

Villemagne, Victor L. ; Doré, Vincent ; Chong, Lee...
Journal of Alzheimer's Disease. 97 (2024) 3 - p. 1463-1475 , 2024

Link: https://doi.org/10.3233/..

2

Xanamem shows pro‐cognitive activity with clinically meanin..:

Hilt, Dana ; Rolan, Paul ; Taylor, Jack...
Alzheimer's & Dementia. 19 (2023) S21 - p. , 2023

Link: https://doi.org/10.1002/..

3

Satisfaction with alemtuzumab in relapsing multiple scleros..:

Wray, Sibyl ; Jacques, Francois ; Miller, Tamara A...
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 8 (2022) 4 - p. 205521732211358 , 2022

Link: https://doi.org/10.1177/..

4

Repository Corticotropin Injection Improves Quality Metrics..:

Kaplan, Jeffrey ; Miller, Tamara ; Baker, Matthew..
Neurodegenerative Disease Management. 11 (2021) 6 - p. 469-476 , 2021

Link: https://doi.org/10.2217/..

5

Results and drug development summary for Xanamem, a potent ..:

Ritchie, Craig W. ; Miller, Tamara ; Ketelbey, John W.
Alzheimer's & Dementia. 16 (2020) S9 - p. , 2020

Link: https://doi.org/10.1002/..

6

Safety and Efficacy of Ocrelizumab in Patients who Transiti..:

Miller, Paul ; Tran, Vince ; Jarrar, Rawan...
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

7

A Prospective Observational Registry Study of Repository Co..:

Kaplan, Jeffrey ; Miller, Tamara ; Baker, Matthew..
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

8

A Prospective Observational Registry of Repository Corticot..:

Kaplan, Jeffrey ; Miller, Tamara ; Baker, Matthew..
Frontiers in Neurology. 11 (2020) - p. , 2020

Link: https://doi.org/10.3389/..

9

4396 Immunoglobulin administration and hypogammaglobulinemi..:

Edington, Holly ; Chandrakasan, Shanmuganathan ; Miller, Tamara...
Journal of Clinical and Translational Science. 4 (2020) s1 - p. 136-137 , 2020

Link: https://doi.org/10.1017/..

10

11β-hydroxysteroid dehydrogenase type 1 inhibitor use in hu..:

Gregory, Sarah ; Hill, David ; Grey, Ben...
Metabolism. 108 (2020) - p. 154246 , 2020

Link: https://doi.org/10.1016/..

11

Quality of Life Improves with Alemtuzumab Over 6 Years in R..:

Bertolotto, Antonio ; Arroyo, Rafael ; Celius, Elisabeth G....
Neurology and Therapy. 9 (2020) 2 - p. 443-457 , 2020

Link: https://doi.org/10.1007/..

12

Treatment Sequencing and Satisfaction With Alemtuzumab in R..:

Wray, Sibyl ; Jacques, Francois ; Miller, Tamara A....
Neurology. 92 (2019) 15_supplement - p. , 2019

Link: https://doi.org/10.1212/..

13

Adrenal Insufficiency and Multiorgan Failure in a Patient R..:

Miller, Paul ; Tran, Vince ; Miravalle, Augusto.
Neurology. 92 (2019) 15_supplement - p. , 2019

Link: https://doi.org/10.1212/..

14

The Effect of Ocrelizumab Therapy on Immunoglobulin Levels ..:

Tran, Vincent ; Miller, Paul ; Olson, Jill..
Neurology. 92 (2019) 15_supplement - p. , 2019

Link: https://doi.org/10.1212/..

15

P3‐003: 11‐β HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS..:

Gregory, Sarah ; Hill, David ; Ketelbey, John W....
Alzheimer's & Dementia. 15 (2019) 7S_Part_17 - p. , 2019

Link: https://doi.org/10.1016/..